（文章来源：证券日报） 证券日报网讯 8月4日晚间，森鹰窗业发布公告称，公司第九届监事会第十九次会议审议通过了《关于 使用自有资金支付募投项目所需资金并以募集资金等额置换的议案》。 ...

证券日报网讯 8月4日晚间，森鹰窗业发布公告称，公司第九届董事会第二十三次会议审议通过了《关 于使用自有资金支付募投项目所需资金并以募集资金等额置换的议案》。 （文章来源：证券日报） ...

Group 1 - The core point of the article is that Senying Windows (SZ 301227) announced a board meeting on August 4, 2025, to discuss the use of self-owned funds to pay for fundraising project needs and to replace the raised funds with equivalent amounts [2] - In the fiscal year 2024, the revenue composition of Senying Windows is as follows: 71.29% from wooden door and window manufacturing, 25.69% from metal door and window manufacturing, 2.65% from other businesses, and 0.37% from plastic door and window manufacturing [2]

关于哈尔滨森鹰窗业股份有限公司 使用自有资金支付募投项目所需资金并以募集资金等额置换 的核查意见 作为哈尔滨森鹰窗业股份有限公司（以下简称"森鹰窗业"或"公司"）首 次公开发行股票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理 办法》、《上市公司募集资金监管规则》、《深圳证券交易所创业板股票上市规则 （2025 年修订）》及《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作（2025 年修订）》等有关规定，对公司使用自有资金支付募投 项目所需资金并以募集资金等额置换的事项进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意哈尔滨森鹰窗业股份有限公司首次公 开发行股票注册的批复》（证监许可〔2022〕1442 号）同意注册，并经深圳证券 交易所同意，公司首次公开发行人民币普通股（A 股）2,370.00 万股，每股面值 人民币 1.00 元，每股发行价格为 38.25 元，募集资金总额为 90,652.50 万元，扣 除发行费用后，实际募集资金净额为 82,370.21 万元。天健会计师事务所（特殊 普通合伙）于 2022 年 9 月 20 日对 ...

证券代码：301227 证券简称：森鹰窗业 公告编号：2025-071 关于使用自有资金支付募投项目所需资金 并以募集资金等额置换的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 哈尔滨森鹰窗业股份有限公司（以下简称"公司"）于2025年8月4日分别 召开第九届董事会第二十三次会议和第九届监事会第十九次会议，审议通过了 《关于使用自有资金支付募投项目所需资金并以募集资金等额置换的议案》， 同意公司在募投项目实施期间，根据实际情况先行使用自有资金支付募投项目 所需资金，在履行内部相关审批程序后以募集资金等额置换，该部分等额置换 资金视同募投项目使用资金。保荐机构对该事项出具了无异议的核查意见。该 事项在董事会审批权限范围内，无需提交股东大会审议。现将相关情况公告如 下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意哈尔滨森鹰窗业股份有限公司首次 公开发行股票注册的批复》（证监许可〔2022〕1442号）同意注册，并经深圳 证券交易所同意，公司首次公开发行人民币普通股（A股）2,370.00万股，每股 面值人民币1.00元，每股发行价格为38.2 ...

哈尔滨森鹰窗业股份有限公司 第九届监事会第十九次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：301227 证券简称：森鹰窗业 公告编号：2025-070 监事会同意公司在募投项目实施期间，根据实际情况先行使用自有资金支 付募投项目所需资金，在履行内部相关审批程序后以募集资金等额置换。 具体内容详见公司披露于巨潮资讯网（http://www.cninfo.com.cn）的相关公 告。 表决结果：同意3票；反对0票；弃权0票。 1 三、备查文件 一、监事会会议召开情况 哈尔滨森鹰窗业股份有限公司（以下简称"公司"）第九届监事会第十九 次会议于2025年8月4日在公司会议室以现场方式召开。本次会议通知于2025年7 月30日以邮件方式发出，会议应出席监事3人，实际出席监事3人。会议由监事 会主席赵丽丽女士召集并主持。本次会议的召集、召开符合《公司法》《证券 法》等法律、法规、规范性文件及《公司章程》的有关规定，会议合法有效。 二、监事会会议审议情况 经与会监事审议并以记名投票表决的方式，审议并通过了如下议案： （一）审议通过《关于使用自有 ...

证券代码：301227 证券简称：森鹰窗业 公告编号：2025-069 经与会董事审议并以记名投票表决的方式，审议并通过了如下议案： （一）审议通过《关于使用自有资金支付募投项目所需资金并以募集资金 等额置换的议案》 公司募投项目涉及从境外购买设备，其产生的进口增值税、关税等相关税 金，需通过公司与海关、税务等系统绑定的账户统一支付，无法通过募集资金 专户直接支付。董事会同意公司在募投项目实施期间，根据实际情况先行使用 自有资金支付募投项目所需资金，在履行内部相关审批程序后以募集资金等额 置换，该部分等额置换资金视同募投项目使用资金。 保荐机构对本议案发表了无异议的核查意见，具体内容详见公司披露于巨 潮资讯网（http://www.cninfo.com.cn）的相关公告。 表决结果：同意7票；反对0票；弃权0票。 哈尔滨森鹰窗业股份有限公司 第九届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 哈尔滨森鹰窗业股份有限公司（以下简称"公司"）第九届董事会第二十 三次会议于2025年8月4日在公司会议室以通讯结 ...

Group 1: Company Performance - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of the year, a year-on-year increase of 101.92% [1] - The company's revenue for the first half reached 20.799 billion yuan, reflecting a growth of 20.64% year-on-year [1] - WuXi AppTec plans to distribute a cash dividend of 3.5 yuan per share to all shareholders [1] - The company has revised its revenue forecast for the full year to between 42.5 billion and 43.5 billion yuan [1] - SANY Heavy Industry plans to issue non-financial corporate debt financing tools not exceeding 20 billion yuan to optimize its financing structure [1] Group 2: Film Industry Impact - Happiness Blue Sea announced that the film "Nanjing Photo Studio" has surpassed 412 million yuan in cumulative box office, exceeding 50% of the company's audited revenue for the most recent fiscal year [2] - The film's impact on the company's revenue is currently negligible as it is still in theaters [2] Group 3: Corporate Actions - Zhonghua Equipment plans to issue shares to acquire 100% equity of two companies, marking a significant asset restructuring [2] - Dahua Intelligent is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [3] - Shiming Technology's actual controller and chairman has been placed under detention due to personal matters unrelated to the company [4] Group 4: Financial Performance - Ju Chen Co. reported a net profit growth of 43.5% for the first half of the year [6] - Qizheng Tibetan Medicine's net profit increased by 9.94% year-on-year [6] - China Minmetals' new contract value decreased by 19.1% year-on-year [6] - Huicheng Environmental's net profit declined by 85.63% year-on-year [6] Group 5: Mergers and Acquisitions - Kaishan Holdings plans to acquire a minority stake in SMGP for 3 million USD [6] - Zhonghua International intends to purchase 100% equity of Nantong Xingchen Composite Materials Co., Ltd. [6] - Xiangdian Co. plans to acquire a 12.5% stake in Tongda Electromagnetic Energy for 208 million yuan [6]

Group 1: Suspension and Resumption of Trading - Sinochem International plans to acquire 100% equity of Nantong Xingchen from Bluestar Group through share issuance, leading to the resumption of its stock trading [1] Group 2: Mergers and Acquisitions - Xuefeng Technology intends to acquire 51% equity of Shengshi Putian for 154 million yuan [2] Group 3: Investment Cooperation and Operational Status - Hengshuai Co., Ltd. has adopted harmonic magnetic field motor technology to provide customized solutions in the humanoid robot field [3] - Fuchun Dyeing and Weaving focuses on new business applications of PEEK, including semiconductor, medical devices, and lightweight solutions for humanoid robots [3] - Jingsong Intelligent is progressing as planned in the development of its first-generation wheeled humanoid robot product [3] - Annoqi's production project for 30,000 tons of dye intermediates in Yantai is expected to be operational by December 31, 2025 [3] - Fosun Pharma signed a licensing agreement with Newco for the development rights of the AR1001 drug in China [4] - Sanxiang New Materials' subsidiary Liaoning Huaxiang plans to invest no more than 300 million yuan in a zirconium-hafnium separation project [5] - Shandong Gold's Shanjin International plans to issue H-shares and apply for listing on the main board of the Hong Kong Stock Exchange [6] - Hengxin Life intends to invest 505 million yuan in the construction of a biodegradable product production base [7] - Zoomlion has won bids in ongoing projects for hydropower in Yaxi [8] - Huhua Co., Ltd. plans to raise no more than 586 million yuan through a private placement, with net proceeds allocated to various projects including the automation and information transformation of civil explosive production lines [8] Group 4: Performance Changes - WuXi AppTec's net profit for the first half of 2025 is projected to be 8.561 billion yuan, a year-on-year increase of 101.92%, with a focus on CRDMO core business [9] - Jucheng Co., Ltd. expects a net profit of 205 million yuan for the first half of 2025, a year-on-year increase of 43.5%, driven by the growing demand for DDR5 memory modules [9] - Zhongke Environmental's net profit for the first half of 2025 is projected to be 196 million yuan, a year-on-year increase of 19.83%, supported by expanded waste treatment and heating markets [9] - Zhongke Sanhuan's net profit for the first half of 2025 is expected to be 43.9931 million yuan, a year-on-year increase of 160.82% [10]

Core Viewpoint - The legal opinion letter from Shanghai Junlan Law Firm confirms that Harbin Senying Window Industry Co., Ltd. has made adjustments to its 2025 restricted stock incentive plan, including changes to the number of incentive recipients and the total number of restricted stocks to be granted [1][5][9] Group 1: Adjustments to the Incentive Plan - The number of incentive recipients has been reduced from 98 to 46, and the total number of restricted stocks granted has been adjusted from 4 million shares to 2 million shares [5][6] - The adjustments were made due to some recipients no longer meeting the criteria for the incentive plan and others voluntarily giving up their eligibility [5][6] Group 2: Granting Conditions - The board of directors has set July 18, 2025, as the grant date for the restricted stocks, with a grant price of 13.10 yuan per share [6][9] - The granting conditions have been confirmed to be met, and there are no disqualifying circumstances for the company or the incentive recipients [7][9] Group 3: Compliance and Disclosure - The adjustments and grants have been approved in accordance with relevant regulations, including the Management Measures for Equity Incentives and the Listing Rules [5][9] - The company is required to fulfill its information disclosure obligations in a timely manner, including announcements related to the adjustments and grants [6][9]